Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ISRG
stocks logo

ISRG

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
2.72B
+12.86%
2.242
+1.46%
2.61B
+15.95%
2.117
+16.98%
2.78B
+14.14%
2.419
+10.48%
Estimates Revision
The market is revising Upward the revenue expectations for Intuitive Surgical, Inc. (ISRG) for FY2025, with the revenue forecasts being adjusted by 1.41% over the past three months. During the same period, the stock price has changed by 21.80%.
Revenue Estimates for FY2025
Revise Upward
up Image
+1.41%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+5.97%
In Past 3 Month
Stock Price
Go Up
up Image
+21.80%
In Past 3 Month
Wall Street analysts forecast ISRG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ISRG is 612.47 USD with a low forecast of 440.00 USD and a high forecast of 700.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
20 Analyst Rating
Wall Street analysts forecast ISRG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ISRG is 612.47 USD with a low forecast of 440.00 USD and a high forecast of 700.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
16 Buy
3 Hold
1 Sell
Strong Buy
Current: 568.630
sliders
Low
440.00
Averages
612.47
High
700.00
Current: 568.630
sliders
Low
440.00
Averages
612.47
High
700.00
Freedom Capital
Ilya Zubkov
Hold
maintain
$475 -> $560
2025-10-28
Reason
Freedom Capital
Ilya Zubkov
Price Target
$475 -> $560
2025-10-28
maintain
Hold
Reason
Freedom Capital analyst Ilya Zubkov raised the firm's price target on Intuitive Surgical to $560 from $475 and keeps a Hold rating on the shares after "better-than-expected" Q3 earnings. Freedom Capital told investors that despite margin pressure from tariffs and mix, operating leverage and robust demand propelled profitability ahead of expectations, prompting a sharp post-print re-rating despite year-to-date underperformance versus the sector and the broader market. The firm said it maintained a Hold rating as positive expectations may already be reflected in the current valuation.
UBS
Neutral
maintain
$585 -> $600
2025-10-23
Reason
UBS
Price Target
$585 -> $600
2025-10-23
maintain
Neutral
Reason
UBS raised the firm's price target on Intuitive Surgical to $600 from $585 and keeps a Neutral rating on the shares. Strong procedure volume growth and system placements are likely to help sustain the stock's momentum, the analyst tells investors in a post-earnings note.
RBC Capital
Outperform
maintain
$615 -> $625
2025-10-22
Reason
RBC Capital
Price Target
$615 -> $625
2025-10-22
maintain
Outperform
Reason
RBC Capital raised the firm's price target on Intuitive Surgical to $625 from $615 and keeps an Outperform rating on the shares. The company delivered a solid earnings beat, delivering upside surprise of 4% and 20% on sales and EPS, respectively, the analyst tells investors in a research note. The stock also rose thanks to the positive total/dv5 placements, procedure volume raise, and a notable 20% EPS beat as the report helped dispel investor concerns coming into the quarter on dV5 adoption/ramp, hospital environment, and re-manufacturers, RBC adds, noting that it is overall bullish on Intuitive's prospects as Q3 marks the beginning of the trade-in and multi-year replacement cycle for the company.
Mizuho
Anthony Petrone
Neutral
maintain
$520 -> $575
2025-10-22
Reason
Mizuho
Anthony Petrone
Price Target
$520 -> $575
2025-10-22
maintain
Neutral
Reason
Mizuho analyst Anthony Petrone raised the firm's price target on Intuitive Surgical to $575 from $520 and keeps a Neutral rating on the shares. The firm views the company's Q3 beat shows it can maintain its "bellwether" growth status. However, this is already priced into the shares, the analyst tells investors in a research note.
Truist
Buy
maintain
$525 -> $620
2025-10-22
Reason
Truist
Price Target
$525 -> $620
2025-10-22
maintain
Buy
Reason
Truist raised the firm's price target on Intuitive Surgical to $620 from $525 and keeps a Buy rating on the shares. The company delivered a second consecutive quarter of above 20% revenue and EPS growth, accelerating from Q2, behind a strong beat on almost all key metrics, including boxes, procedures, and utilization, the analyst tells investors in a research note.
BTIG
Buy
maintain
$529 -> $589
2025-10-22
Reason
BTIG
Price Target
$529 -> $589
2025-10-22
maintain
Buy
Reason
BTIG raised the firm's price target on Intuitive Surgical to $589 from $529 and keeps a Buy rating on the shares following the Q3 report. The company posted strong procedure growth and unit placements, the analyst tells investors in a research note. BTIG believes the stock is positioned "for a bounce" given the growing short interest into the earnings print. The firm continues to believe Intuitive Surgical has "meaningful runway" in its trade-in cycle and while procedure demand is "healthy."
See All Ratings

Valuation Metrics

The current forward P/E ratio for Intuitive Surgical Inc (ISRG.O) is 61.43, compared to its 5-year average forward P/E of 57.19. For a more detailed relative valuation and DCF analysis to assess Intuitive Surgical Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
57.19
Current PE
61.43
Overvalued PE
66.78
Undervalued PE
47.60

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
38.54
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
45.56
Undervalued EV/EBITDA
31.51

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
16.44
Current PS
0.00
Overvalued PS
19.48
Undervalued PS
13.39
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress areBuying! The buying amount has increased837.5%over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

ISRG News & Events

Events Timeline

(ET)
2025-10-22
12:02:06
Intuitive Surgical Shares Surge by 15.2%
select
2025-10-22
10:01:25
Intuitive Surgical Sees 17.0% Increase
select
2025-10-22
09:55:01
Significant Early Gainers in Liquid Options on October 22nd
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.0
12-04Newsfilter
Medtronic's Hugo Robot Receives FDA Clearance for Urologic Procedures, Paving Way for 2026 Sales Growth
  • Market Entry Breakthrough: Medtronic's Hugo surgical robot has received FDA clearance for urologic procedures, marking a significant milestone for its official entry into the U.S. market and is expected to drive substantial sales growth for the company.
  • Sales Growth Expectations: With FDA approval, Medtronic anticipates that the Hugo robot will achieve sales growth by 2026, further solidifying its market position in the medical robotics sector.
  • Innovation-Driven Technology: The Hugo robot integrates advanced surgical technology and remote operation capabilities, not only enhancing surgical efficiency but also providing greater operational flexibility for surgeons, thereby improving patient treatment experiences.
  • Strategic Market Positioning: This FDA approval lays the groundwork for Medtronic's expansion in the urology sector, expected to attract more healthcare institutions to adopt this technology, thereby strengthening the company's competitive edge in the highly contested medical device market.
[object Object]
Preview
4.5
12-04NASDAQ.COM
Significant ETF Inflows: QQQI, TMUS, ISRG, PEP

  • 52-Week Range of QQQI: QQQI's share price has a 52-week low of $41.1701 and a high of $55.93, with the last trade recorded at $54.59.

  • Understanding ETFs: Exchange-traded funds (ETFs) function like stocks, where investors buy and sell "units" that can be created or destroyed based on demand.

  • Monitoring ETF Flows: Weekly monitoring of shares outstanding helps identify ETFs with significant inflows (new units created) or outflows (units destroyed), impacting the underlying holdings.

  • Author's Views: The opinions expressed in the article are those of the author and do not necessarily represent Nasdaq, Inc.

[object Object]
Preview
9.0
12-04Benzinga
Medtronic Achieves FDA Approval as Hugo Surgical Robot Enters 230,000 Urology Procedures Market

  • FDA Clearance: The FDA has approved Medtronic's Hugo robotic-assisted surgery system for urologic procedures, enhancing access to minimally invasive surgical options in the U.S.

  • Surgical Applications: The Hugo RAS system is indicated for common urologic surgeries such as prostatectomy, nephrectomy, and cystectomy, which collectively account for approximately 230,000 surgeries annually in the U.S.

  • Clinical Study Success: The Expand URO clinical study confirmed the safety and effectiveness of the Hugo RAS system, achieving a 100% surgical success rate in hernia repair procedures.

  • Market Impact: Analysts expect Medtronic's sales from the Hugo system to begin contributing in fiscal 2026, with a significant impact anticipated in fiscal 2027, despite competition from Intuitive Surgical.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Intuitive Surgical Inc (ISRG) stock price today?

The current price of ISRG is 568.63 USD — it has decreased -0.19 % in the last trading day.

arrow icon

What is Intuitive Surgical Inc (ISRG)'s business?

Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.

arrow icon

What is the price predicton of ISRG Stock?

Wall Street analysts forecast ISRG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ISRG is 612.47 USD with a low forecast of 440.00 USD and a high forecast of 700.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Intuitive Surgical Inc (ISRG)'s revenue for the last quarter?

Intuitive Surgical Inc revenue for the last quarter amounts to 2.51B USD, increased 22.91 % YoY.

arrow icon

What is Intuitive Surgical Inc (ISRG)'s earnings per share (EPS) for the last quarter?

Intuitive Surgical Inc. EPS for the last quarter amounts to 1.95 USD, increased 25.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Intuitive Surgical Inc (ISRG)'s fundamentals?

The market is revising Upward the revenue expectations for Intuitive Surgical, Inc. (ISRG) for FY2025, with the revenue forecasts being adjusted by 1.41% over the past three months. During the same period, the stock price has changed by 21.80%.
arrow icon

How many employees does Intuitive Surgical Inc (ISRG). have?

Intuitive Surgical Inc (ISRG) has 15638 emplpoyees as of December 05 2025.

arrow icon

What is Intuitive Surgical Inc (ISRG) market cap?

Today ISRG has the market capitalization of 201.58B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free